Efavirenz

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor

Efavirenz contraindicated conditions:

Efavirenz desired effects:

  • Decreased Reverse Transcription to DNA

Efavirenz drug classes:

  • Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor

Efavirenz pharmacologic actions:

  • Reverse Transcriptase Inhibitors
  • Cytochrome P-450 CYP2C19 Inhibitors
  • Cytochrome P-450 CYP2C9 Inhibitors
  • Cytochrome P-450 CYP2B6 Inducers
  • Anti-HIV Agents
  • Cytochrome P-450 CYP3A Inducers

Efavirenz mechanism of action:

  • Cytochrome P450 2C9 Inhibitors
  • Cytochrome P450 3A Inducers
  • Cytochrome P450 2C19 Inhibitors
  • Cytochrome P450 2B6 Inducers
  • Cytochrome P450 3A4 Inhibitors
  • Non-Nucleoside Reverse Transcriptase Inhibitors
  • treatable

The content offered on Treatable.org is intended for informational purposes only and not as medical advice. For medical advice you should consult an appropriately licensed and qualified medical professional. If you are experiencing acute or distressing symptoms or life threatening symptoms you should immediately call 911 and/or go to the nearest emergency medical facility.

Copyright © Treatable 2022
Last updated: 9/29/2022, 6:27:59 PM